Glycan microarray reveal induced
Sequential patients' serum samples pre-/post-ATG therapy were tested at 1:100 dilution on sialoglycan microarrays, detected by Cy3-antihuman IgG (40 ng/well) (repeated measures One-Way ANOVA, *** P<0.0001, with Bonferroni's Multiple Comparison Test). (B) Serum anti-Neu5Gc IgG repertoire measured against Neu5Gc-glycans pre-ATG (M0) and one month post-ATG (M1) revealed newly-derived antibodies (Heatmap per serum: red-white-blue represent maximum-50th percentile-minimum reactivity, respectively).
